You are here

Ribopharma AG

Alnylam Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Broadly Covering RNAi Therapeutics that Target Mutated Genes

Yahoo/BusinesWire

Thu, 06/17/10 - 08:48 am